PATENT CLAIM ANALYSIS

Application Number: 15748691
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["514", "449000"]

Abstract:
The present invention provides a pharmaceutical composition for oral administration, comprising (a) 4 to 40% by weight of a taxane, (b) 10 to 30% by weight of a medium chain triglyceride, (c) 30 to 70% by weight of monooleoyl glycerol, (d) 5 to 30% by weight of a surfactant, and (e) 10 to 30% by weight of polyoxyl glyceryl fatty acid ester and a process for preparing the same.

Claim (Index 5):
The pharmaceutical composition for oral administration according to  claim 1 , wherein the medium chain triglyceride is one or more selected from the group consisting of triacetin, tripropionin, tributyrin, trivalerin, tricaproin, tricaprylin, tricaprin, triheptanoin, trinonanoin, triundecanoin, trilaurin, tritridecanoin, trimyristin, tripentadecanoin, tripalmitin, glyceryl triheptadecanoate, and triolein.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 86.0
- Lexical Diversity: 1.91489
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15523021', '09281430', '15454898', '14690289', '10047902']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8463169405577989
- 35 USC 102 Novelty (BERT): 0.5816508305824336
- Combined Prediction Score: 0.8198503295602624
- Mean Citation Score: 314.50464
- Max Citation Score: 477.9424
- Similarity Product: 474.81366529769895

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test